Multiple sclerosis (8)
multiple sclerosis (3)
Cerebrospinal fluid (2)
Demyelinating diseases (2)
generalized myasthenia gravis (2)
Ocrelizumab (2)
Oligoclonal bands (2)
Psychological support (2)
quality of life (2)
repetitive nerve stimulation (2)
Social interaction (2)
Stigma (2)
Workplace challenges (2)
Adult-onset multiple sclerosis (1)
Aging (1)
antineutrophil autoantibodies (1)
antinuclear autoantibodies (1)
anxiety (1)
Anxiety (1)
autoimmunity (1)
autonomic neuropathy (1)
cerebellar vermis (1)
cerebral palsy (1)
Cerebral venous sinus thrombosis (1)
Cladribine (1)
Clinical characteristics (1)
cognitive dysfunction (1)
Cognitive function (1)
Cognitive performance (1)
Cubital Tunnel Syndrome (1)
Decreased (1)
Decretion (1)
depression (1)
Depression (1)
Diabetes mellitus (1)
Differential diagnosis (1)
digital health (1)
Disease progression (1)
Disease reactivation (1)
Disease-modifying therapies (DMTs) (1)
drug administration schedule (1)
Drug-related side effects and adverse reactions (1)
Electrodiagnosis (1)
electromyography (1)
et's syndrome (1)
et's Syndrome, parenchymal neuro-Beh & ccedil (1)
Expanded disability status scale (EDSS) (1)
fatigue (1)
Fingolimod (1)
Fingolimod hydrochloride (1)
Functional outcomes (1)
gait disorders (1)
Hepatotoxicity (1)
IgG levels (1)
Immunoglobulin G (1)
Immunology (1)
Late -onset (1)
Late-onset multiple sclerosis (1)
Liver function tests (LFTs) (1)
magnetic resonance imaging (1)
Magnetic resonance imaging (1)
Median Nerve (1)
Mental health (1)
Migraine (1)
mobility limitation (1)
MOGAD (1)
multiple sclerosis progression (1)
Myelin oligodendrocyte glycoprotein (1)
natalizumab (1)
Nervous system involvement (1)
Neuro-Beh & ccedil (1)
Neuroimaging (1)
Neurology (1)
Neuromuscular disease (1)
Neuromyelitis optica spectrum disorders (1)
Neuropathic pain (1)
NMOSD (1)
Pain management (1)
patient engagement (1)
Patient reported outcome (1)
patient reported outcomes (1)
Patient satisfaction (1)
Pediatric-onset multiple sclerosis (1)
personalized medicine (1)
Pregnancy (1)
prognosis (1)
Prognosis (1)
Quality of life (1)
Recurrence (1)
Relapsing-remitting (1)
relapsing-remitting multiple sclerosis (1)
Relapsing-remitting multiple sclerosis (RRMS) (1)
respiratory function tests (1)
Restless genital syndrome (1)
restless leg syndrome (1)
Rhombencephalosynapsis (1)
R-R interval (1)
telerehabilitation (1)
Transaminases (1)
trapezius muscle (1)
treatment adherence and compliance (1)
Treatment outcome (1)
Treatment response (1)
Treatment transition (1)
Turkey (1)
Ulnar Nerve (1)
walking speed (1)
Washout period (1)
Wearing-off phenomenon (1)
